Abstract
Adaptor proteins are key regulators of intracellular signaling. Many aspects of their functions have been elucidated and the structures of many members of this family of proteins have been resolved. The adaptor protein Grb2 is a critical component of the cell signaling machinery that is deregulated in several pathological processes, including cancer. A plurality of interactions make Grb2 an important cellular hub linking activated cell surface receptors to downstream targets by binding to specific phosphotyrosine-containing and proline-rich sequence motifs. Its critical roles in epithelial morphogenesis and in processes such as proliferation, actin-based cell motility, invasion, and angiogenesis make it a logical therapeutic target for several pathological processes, including human cancer. In this chapter Grb2 will be used as a paradigm to illustrate how adaptor proteins are involved in cancer and how it is possible to selectively target adaptor proteins for cancer therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
T. Pawson, P. Nash, Science 300, 445 (2003).
T. Hunter, Cell 100, 113 (2000).
T. Hunter, Current Opinion in Cell Biology 21, 140 (2009).
T. Pawson, P. Nash, Genes Dev. 14, 1027 (2000).
T. Pawson, Cell 116, 191 (2004).
J. Roskoski, Biochemical and Biophysical Research Communications 324, 1155 (2004).
T. Pawson, Current Opinion in Cell Biology 19, 112 (2007).
D. C. Flynn, Oncogene 20, 6270 (2001).
M. T. Uhlik et al., Journal of Molecular Biology 345, 1 (2005).
I. Sadowski, J. C. Stone, T. Pawson, Mol. Cell. Biol. 6, 4396 (1986).
T. Pawson, Oncogene 3, 491 (1988).
L. E. M. Marengere, T. Pawson, Journal of Cell Science 107, 97 (1994).
E. Y. Skolnik et al., Cell 65, 83 (1991).
E. J. Lowenstein, Cell 70, 431 (1992).
K. Matuoka, M. Shibata, A. Yamakawa, T. Takenawa, Proceedings of the National Academy of Sciences of the United States of America 89, 9015 (1992).
B. Margolis et al., Proceedings of the National Academy of Sciences of the United States of America 89, 8894 (1992).
D. Stein et al., EMBO Journal 13, 1331 (1994).
J. Manser, W. B. Wood, Developmental Genetics 11, 49 (1990).
T. L. Shen, J. L. Guan, Frontiers in Bioscience 9, 192 (2004).
M. A. Lim, H. Riedel, F. Liu, Frontiers in Bioscience 9, 387 (2004).
E. J. Lowenstein et al., Cell 70, 431 (1992).
P. G. Dharmawardana, B. Peruzzi, A. Giubellino, J. Burke, D. P. Bottaro, Anti-Cancer Drugs 17, 13 (2006).
A. M. Tari, G. Lopez-Berestein, Seminars in Oncology 28, 142 (2001).
A. M. Cheng et al., Cell 95, 793 (1998).
T. M. Saxton et al., Current Biology 11, 662 (2001).
I. Fath et al., Science 264, 971 (1994).
I. Rey et al., Cell Death and Differentiation 2, 105 (1995).
F. Romero, The Journal of biological chemistry 273, 7776 (1998).
S. K. Liu, C. J. McGlade, Oncogene 17, 3073 (1998).
N. Dimasi, International Journal of Biochemistry and Cell Biology 39, 109 (2007).
G. S. Feng et al., J. Biol. Chem. 271, 12129 (1996).
S. Li, A. D. Couvillon, B. B. Brasher, R. A. Van Etten, EMBO Journal 20, 6793 (2001).
K. Huebner et al., Genomics 22, 281 (1994).
A. M. Pendergast et al., Cell 75, 175 (1993).
R. J. Daly, M. D. Binder, R. L. Sutherland, Oncogene 9, 2723 (1994).
B. S. Verbeek, S. S. driaansen-Slot, G. Rijksen, T. M. Vroom, Journal of Pathology 183, 195 (1997).
X. P. Zang, D. R. Siwak, T. X. Nguyen, A. M. Tari, J. T. Pento, Clinical and Experimental Metastasis 21, 437 (2004).
T. Watanabe et al., IUBMB Life 49, 317 (2000).
U. K. Misra, S. V. Pizzo, Cellular Signalling 16, 487 (2004).
G. Z. Yu, Y. Chen, J. J. Wang, Journal of Cancer Research and Clinical Oncology, in press.
G. Z. Yu et al., Oncology Reports 19, 1191 (2008).
B. Gay et al., J. Biol. Chem. 274, 23311 (1999).
N. Atabey et al., J. Biol. Chem. 276, 14308 (2001).
A. Giubellino et al., Cancer Res 67, 6012 (2007).
G. Christofori, Nature 441, 444 (2006).
P. S. Steeg, D. Theodorescu, Nature Clinical Practice Oncology 5, 206 (2008).
I. J. Fidler, Nat Rev Cancer 3, 453 (2003).
P. S. Steeg, Nat Med 12, 895 (2006).
J. Downward, FEBS Letters 338, 113 (1994).
U. Cavallaro, G. Christofori, Nat Rev Cancer 4, 118 (2004).
K. A. Paschos, D. Canovas, N. C. Bird, Cellular Signalling 21, 665 (2009).
S. K. Mitra, D. A. Hanson, D. D. Schlaepfer, Nat Rev Mol Cell Biol 6, 56 (2005).
B. D. Cox, M. Natarajan, M. R. Stettner, C. L. Gladson, Journal of Cellular Biochemistry 99, 36 (2006).
G. W. McLean et al., Nat Rev Cancer 5, 505 (2005).
D. D. Schlaepfer, S. K. Hanks, T. Hunter, P. Van der Geer, Nature 372, 786 (1994).
E. Avizienyte et al., Nat Cell Biol 4, 632 (2002).
R. B. Hazan, R. Qiao, R. Keren, I. Badano, K. Suyama, Annals of the New York Academy of Sciences 1014, 155 (2004).
S. Miyamoto et al., Journal of Cell Biology 131, 791 (1995).
D. D. Schlaepfer, K. C. Jones, T. Hunter, Mol. Cell. Biol. 18, 2571 (1998).
C. J. Malemud, Frontiers in Bioscience 11, 1696 (2006).
M. D. Martin, L. M. Matrisian, Cancer and Metastasis Reviews 26, 717 (2007).
M. L. Moss, M. H. Lambert, Essays in Biochemistry 38, 141 (2002).
C. P. Blobel, Nat Rev Mol Cell Biol 6, 32 (2005).
B. B. Zhou et al., Expert Opinion on Investigational Drugs 14, 591 (2005).
J. S. Fridman et al., Clin Cancer Res 13, 1892 (2007).
A. Suzuki et al., Oncogene 19, 5842 (2000).
Z. Poghosyan et al., J. Biol. Chem. 277, 4999 (2002).
C. Birchmeier, W. Birchmeier, E. Gherardi, G. F. Vande Woude, Nat Rev Mol Cell Biol 4, 915 (2003).
J. F. Lai et al., J. Biol. Chem. 275, 7474 (2000).
A. J. Ridley, P. M. Comoglio, A. Hall, Mol. Cell. Biol. 15, 1110 (1995).
G. Hartmann, K. M. Weidner, H. Schwarz, W. Birchmeier, J. Biol. Chem. 269, 21936 (1994).
H. She et al., Mol. Biol. Cell 8, 1709 (1997).
H. D. Ochs, A. J. Thrasher, Journal of Allergy and Clinical Immunology 117, 725 (2006).
P. Aspenstrom, U. Lindberg, A. Hall, Current Biology 6, 70 (1996).
N. Scaplehorn et al., Current Biology 12, 740 (2002).
M. F. Carlier, C. Le Clainche, S. Wiesner, D. Pantaloni, Bioessays 25, 336 (2003).
H. N. Higgs, T. D. Pollard, Annual Review of Biochemistry 70, 649 (2001).
M. F. Carlier et al., J. Biol. Chem. 275, 21946 (2000).
R. Kumar, A. E. Gururaj, C. J. Barnes, Nat Rev Cancer 6, 459 (2006).
E. Manser, T. Leung, H. Salihuddin, Z. S. Zhao, L. Lim, Nature 367, 40 (1994).
L. A. Puto, K. Pestonjamasp, C. C. King, G. M. Bokoch, J. Biol. Chem. 278, 9388 (2003).
H. Yamaguchi et al., J. Cell Biol. 168, 441 (2005).
T. Wiederhold et al., Oncogene 23, 8815 (2004).
L. Crostella, S. Lidder, R. Williams, G. G. Skouteris, Oncogene 20, 3735 (2001).
N. Martinez-Quiles, H. Y. H. Ho, M. W. Kirschner, N. Ramesh, R. S. Geha, Mol. Cell. Biol. 24, 5269 (2004).
A. M. Weaver, Clinical and Experimental Metastasis 23, 97 (2006).
E. S. Clark, A. S. Whigham, W. G. Yarbrough, A. M. Weaver, Cancer Res 67, 4227 (2007).
J. L. Boerner et al., Oncogene 22, 6679 (0AD).
A. Hall, Annual Review of Cell Biology 10, 31 (1994).
L. Spinardi, P. C. Marchisio, European Journal of Cell Biology 85, 191 (2006).
L. Spinardi et al., Experimental Cell Research 295, 360 (2004).
M. Sahni et al., J. Biol. Chem. 271, 33141 (1996).
Y. F. Liu, R. C. Deth, D. Devys, J. Biol. Chem. 272, 8121 (1997).
R. W. L. Lim, S. Halpain, J. Biol. Chem. 275, 20578 (2000).
K. J. Luzzi et al., Am J Pathol 153, 865 (1998).
J. Folkman, Seminars in Oncology 29, 15 (2002).
J. Kroll, J. Waltenberger, J. Biol. Chem. 272, 32521 (1997).
E. Fournier et al., Oncogene 18, 507 (1999).
J. V. Soriano et al., Molecular Cancer Therapeutics 3, 1289 (2004).
T. Shono, H. Kanetake, S. Kanda, Experimental Cell Research 264, 275 (2001).
K. V. Stoletov, K. E. Ratcliffe, B. I. Terman, The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 16, 1283 (2002).
S. Hiscox, W. G. Jiang, Biochemical and Biophysical Research Communications 233, 1 (1997).
N. Kawakami-Kimura et al., British Journal of Cancer 75, 47 (1997).
E. M. Rosen et al., CIBA Foundation Symposia 215 (1997).
M. Rosario, W. Birchmeier, Trends in Cell Biology 13, 328 (2003).
K. Matsumoto, T. Nakamura, Cancer Science 94, 321 (2003).
S. K. Mitra et al., Oncogene 25, 5969 (2006).
Y. Seko et al., Biochemical and Biophysical Research Communications 262, 290 (1999).
A. E. Aplin, A. Howe, S. K. Alahari, R. L. Juliano, Pharmacological Reviews 50, 197 (1998).
B. Brenner et al., Proceedings of the National Academy of Sciences 93, 15376 (1996).
F. Qian, D. Hanahan, I. L. Weissman, Proceedings of the National Academy of Sciences of the United States of America 98, 3976 (2001).
H. W. H. G. Kessels, A. C. Ward, T. N. M. Schumacher, Proceedings of the National Academy of Sciences of the United States of America 99, 8524 (2002).
J. Burke et al., Biochemistry«6490 (1994).
Z. J. Yao et al., Journal of Medicinal Chemistry 42, 25 (1999).
Y. L. Song et al., Journal of Medicinal Chemistry 49, 1585 (2006).
B. Gay et al., International Journal of Cancer 83, 235 (1999).
K. Machida, B. J. Mayer, Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics 1747, 1 (2005).
J. Burke, International Journal of Peptide Research and Therapeutics 12, 33 (2006).
G. Caravatti, J. Rahuel, G. Brigitte, P. Furet, Bioorganic and Medicinal Chemistry Letters 9, 1973 (1999).
N. Atabey et al., Journal of Biological Chemistry 276, 14308 (2001).
A. Giubellino et al., Cancer Research 67, 6012 (2007).
B. K. Kay, M. P. Williamson, M. Sudol, FASEB Journal 14, 231 (2000).
B. J. Mayer, Journal of Cell Science 114, 1253 (2001).
D. M. Berry, P. Nash, S. K. W. Liu, T. Pawson, C. J. McGlade, Current Biology 12, 1336 (2002).
A. R. Viguera, J. L. R. Arrondo, A. Musacchio, M. Saraste, L. Serrano, Biochemistry 33, 10925 (1994).
S. M. Feller, M. Lewitzky, Current Pharmaceutical Design 12, 529 (2006).
M. Harkiolaki et al., EMBO Journal 22, 2571 (2003).
M. R. Ferguson et al., Protein Sci 13, 626 (2004).
J. T. Nguyen, C. W. Turck, F. E. Cohen, R. N. Zuckermann, W. A. Lim, Science 282, 2088 (1998).
C. Kardinal et al., FASEB Journal 14, 1529 (2000).
C. Kardinal et al., Blood 98, 1773 (2001).
S. M. Feller, G. Tuchscherer, J. Voss, Leukemia and Lymphoma 44, 411 (2003).
D. Cussac et al., FASEB Journal 13, 31 (1999).
B. Gril et al., International Journal of Cancer 121, 407 (2007).
M. Vidal et al., Biochemistry 43, 7336 (2004).
C. Oneyama, H. Nakano, S. V. Sharma, Oncogene 21, 2037 (2002).
M. Di Fulvio, K. M. Henkels, J. Gomez-Cambronero, Biochemical and Biophysical Research Communications 357, 737 (2007).
F. Huang, A. Sorkin, Mol. Biol. Cell 16, 1268 (2005).
K. V. Morris, J. J. Rossi, Gene Therapy 13, 553 (2006).
A. Giubellino et al., Journal of Medicinal Chemistry 51, 7459 (2008).
J. Ursini-Siegel, W. J. Muller, Cell Cycle 7, 1936 (2008).
M. Kim et al., Cell 125, 1269 (2006).
S. Antoku, K. Saksela, G. M. Rivera, B. J. Mayer, Journal of Cell Science 121, 3071 (2008).
K. B. Kaplan, J. R. Swedlow, D. O. Morgan, H. E. Varmus, Genes Dev. 9, 1505 (1995).
A. Giubellino, J. Burke, D. P. Bottaro, Expert Opinion on Therapeutic Targets 12, 1021 (2008).
N. Schiering, E. Casale, P. Caccia, P. Giordano, C. Battistini, Biochemistry 39, 13376 (2000).
M. Brehme et al., Proceedings of the National Academy of Sciences of the United States of America 106, 7414 (2009).
K. Strebhardt, A. Ullrich, Nature Reviews Cancer 8, 473 (2008).
T. Pawson, R. Linding, FEBS Letters 582, 1266 (2008).
A. L. Hopkins, Nature Chemical Biology 4, 682 (2008).
L. Kuepfer, M. Peter, U. Sauer, J. Stelling, Nature Biotechnology 25, 1001 (2007).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Giubellino, A. (2012). GRB2 Signaling as a Molecular Target for Cancer. In: Chatterjee, M., Kashfi, K. (eds) Cell Signaling & Molecular Targets in Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-0730-0_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0730-0_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-0729-4
Online ISBN: 978-1-4614-0730-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)